Viveka Roychowdhury

TC Biopharm to start phase II/III studies of ImmuniCell in October

Read more

The Journey From Cow to Consumption

Read more

Mainstreaming AYUSH

Read more

The journey from cow to consumption

Read more

Playing for high stakes

Read more

TC Biopharm to start phase II/III studies of ImmuniCell in October

Read more

Mylan’s One Quality Standard a long way off

Read more

Getting the science right

Read more

New strategies for growth

Read more

Digital India: A new game needs new rules

Read more